Tumor cell heterogeneity and resistance; report from the 2018 Coffey-Holden Prostate Cancer Academy Meeting
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor cell heterogeneity and resistance; report from the 2018 Coffey-Holden Prostate Cancer Academy Meeting
Authors
Keywords
-
Journal
PROSTATE
Volume 79, Issue 3, Pages 244-258
Publisher
Wiley
Online
2018-11-01
DOI
10.1002/pros.23729
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 68 Ga-PSMA PET/CT in Patients with Rising Prostatic-Specific Antigen After Definitive Treatment of Prostate Cancer: Detection Efficacy and Diagnostic accuracy
- (2018) Maged Abdel Galil Hamed et al. ACADEMIC RADIOLOGY
- Peri-prostatic adipose tissue: the metabolic microenvironment of prostate cancer
- (2018) Zeyad D. Nassar et al. BJU INTERNATIONAL
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Current perspectives on bone metastases in castrate-resistant prostate cancer
- (2018) Christopher Logothetis et al. CANCER AND METASTASIS REVIEWS
- Neoadjuvant-intensive androgen deprivation therapy selects for prostate tumor foci with diverse subclonal oncogenic alterations
- (2018) Adam G. Sowalsky et al. CANCER RESEARCH
- Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer
- (2018) Yi-Mi Wu et al. CELL
- Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
- (2018) David A. Quigley et al. CELL
- A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate Cancer
- (2018) David Y. Takeda et al. CELL
- Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing
- (2018) Srinivas R. Viswanathan et al. CELL
- A PDX/Organoid Biobank of Advanced Prostate Cancers Captures Genomic and Phenotypic Heterogeneity for Disease Modeling and Therapeutic Screening
- (2018) Michael L. Beshiri et al. CLINICAL CANCER RESEARCH
- Targeting the Tumor Microenvironment with Immunotherapy for Genitourinary Malignancies
- (2018) Ariel E. Marciscano et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study
- (2018) Rahul Aggarwal et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012
- (2018) Maha Hussain et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: A Comparison With Prostate-Specific Antigen Across Five Randomized Phase III Clinical Trials
- (2018) Glenn Heller et al. JOURNAL OF CLINICAL ONCOLOGY
- Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial
- (2018) Piet Ost et al. JOURNAL OF CLINICAL ONCOLOGY
- A Prospective Comparison of18F-Sodium Fluoride PET/CT and PSMA-targeted18F-DCFBC PET/CT in Metastatic Prostate Cancer
- (2018) Stephanie A Harmon et al. JOURNAL OF NUCLEAR MEDICINE
- 68Ga-PSMA-11 PET/CT in Primary and Recurrent Prostate Carcinoma: Implications for Radiotherapeutic Management in 121 Patients
- (2018) Stefan A. Koerber et al. JOURNAL OF NUCLEAR MEDICINE
- A Comprehensive Analysis of Cribriform Morphology on Magnetic Resonance Imaging/Ultrasound Fusion Biopsy Correlated with Radical Prostatectomy Specimens
- (2018) Matthew Truong et al. JOURNAL OF UROLOGY
- A 17-Gene Genomic Prostate Score Assay Provides Independent Information on Adverse Pathology in the Setting of Combined Multiparametric Magnetic Resonance Imaging Fusion Targeted and Systematic Prostate Biopsy
- (2018) Amirali Salmasi et al. JOURNAL OF UROLOGY
- Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial
- (2018) Thomas Powles et al. LANCET
- Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2018) Noel Clarke et al. LANCET ONCOLOGY
- [ 177 Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study
- (2018) Michael S Hofman et al. LANCET ONCOLOGY
- MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
- (2018) Veeru Kasivisvanathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
- (2018) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Meeting report from the Prostate Cancer Foundation PSMA-directed radionuclide scientific working group
- (2018) Andrea K. Miyahira et al. PROSTATE
- Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma
- (2018) Diana Miao et al. SCIENCE
- Epigenetic reprogramming: A key mechanism driving therapeutic resistance
- (2018) Anjali V. Sheahan et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Patient derived organoids to model rare prostate cancer phenotypes
- (2018) Loredana Puca et al. Nature Communications
- Noninvasive imaging of the PD-1:PD-L1 immune checkpoint: Embracing nuclear medicine for the benefit of personalized immunotherapy
- (2018) Katrijn Broos et al. Theranostics
- Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate Cancer
- (2018) Howard I. Scher et al. JAMA Oncology
- 68Ga PSMA PET/CT predicts complete biochemical response from radical prostatectomy and lymph node dissection in intermediate and high-risk prostate cancer
- (2018) Pim J. van Leeuwen et al. BJU INTERNATIONAL
- Microsatellite instability in prostate cancer and response to immune checkpoint blockade.
- (2018) Wassim Abida et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypomethylation, endogenous retrovirus expression, and interferon signaling in testicular germ cell tumors
- (2018) Michael C. Haffner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Preliminary results on response assessment using 68Ga-HBED-CC-PSMA PET/CT in patients with metastatic prostate cancer undergoing docetaxel chemotherapy
- (2017) Anna Katharina Seitz et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators
- (2017) Lei Wei et al. EUROPEAN UROLOGY
- Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis
- (2017) Armando E. Giuliano et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of68Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer
- (2017) Thomas A. Hope et al. JOURNAL OF NUCLEAR MEDICINE
- Synthesis and Biologic Evaluation of a Novel18F-Labeled Adnectin as a PET Radioligand for Imaging PD-L1 Expression
- (2017) David J. Donnelly et al. JOURNAL OF NUCLEAR MEDICINE
- Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
- (2017) Hashim U Ahmed et al. LANCET
- Revisiting Seed and Soil: Examining the Primary Tumor and Cancer Cell Foraging in Metastasis
- (2017) Amber E. de Groot et al. MOLECULAR CANCER RESEARCH
- Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer
- (2017) Prasenjit Dey et al. NATURE
- Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer
- (2017) Di Zhao et al. NATURE
- Beyond the androgen receptor II: New approaches to understanding and treating metastatic prostate cancer; Report from the 2017 Coffey-Holden Prostate Cancer Academy Meeting
- (2017) Andrea K. Miyahira et al. PROSTATE
- Post prostatectomy outcomes of patients with high-risk prostate cancer treated with neoadjuvant androgen blockade
- (2017) Rana R. McKay et al. PROSTATE CANCER AND PROSTATIC DISEASES
- PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D
- (2017) Eneda Toska et al. SCIENCE
- Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance
- (2017) Sheng Yu Ku et al. SCIENCE
- Cellular determinants and microenvironmental regulation of prostate cancer metastasis
- (2017) Kiera Rycaj et al. SEMINARS IN CANCER BIOLOGY
- Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer
- (2017) Svitlana Tyekucheva et al. Nature Communications
- Host STING-dependent MDSC mobilization drives extrinsic radiation resistance
- (2017) Hua Liang et al. Nature Communications
- Proteogenomic integration reveals therapeutic targets in breast cancer xenografts
- (2017) Kuan-lin Huang et al. Nature Communications
- Loss of function JAK1 mutations occur at high frequency in cancers with microsatellite instability and are suggestive of immune evasion
- (2017) Lee A. Albacker et al. PLoS One
- Labeling Extracellular Vesicles for Nanoscale Flow Cytometry
- (2017) Aizea Morales-Kastresana et al. Scientific Reports
- DNA Hypomethylation Contributes to Genomic Instability and Intestinal Cancer Initiation
- (2016) K. L. Sheaffer et al. Cancer Prevention Research
- Molecular Profiling to Determine Clonality of Serial Magnetic Resonance Imaging/Ultrasound Fusion Biopsies from Men on Active Surveillance for Low-Risk Prostate Cancer
- (2016) Ganesh S. Palapattu et al. CLINICAL CANCER RESEARCH
- Neoadjuvant Enzalutamide Prior to Prostatectomy
- (2016) Bruce Montgomery et al. CLINICAL CANCER RESEARCH
- Ten- and 15-yr Prostate Cancer-specific Mortality in Patients with Nonmetastatic Locally Advanced or Aggressive Intermediate Prostate Cancer, Randomized to Lifelong Endocrine Treatment Alone or Combined with Radiotherapy: Final Results of The Scandinavian Prostate Cancer Group-7
- (2016) Sophie D. Fosså et al. EUROPEAN UROLOGY
- Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer
- (2016) Susan Halabi et al. JOURNAL OF CLINICAL ONCOLOGY
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
- (2016) Jonathan E Rosenberg et al. LANCET
- Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy
- (2016) Se Jin Im et al. NATURE
- Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
- (2016) Himisha Beltran et al. NATURE MEDICINE
- Organoid culture systems for prostate epithelial and cancer tissue
- (2016) Jarno Drost et al. Nature Protocols
- Beyond Seed and Soil: Understanding and Targeting Metastatic Prostate Cancer; Report From the 2016 Coffey-Holden Prostate Cancer Academy Meeting
- (2016) Andrea K. Miyahira et al. PROSTATE
- Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies
- (2016) Radka Stoyanova et al. Oncotarget
- High-Resolution PET Imaging with Therapeutic Antibody-based PD-1/PD-L1 Checkpoint Tracers
- (2016) Michael Hettich et al. Theranostics
- Mutant KRAS Conversion of Conventional T Cells into Regulatory T Cells
- (2016) S. Zdanov et al. Cancer Immunology Research
- Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non–Small-Cell Lung Cancer
- (2016) Joseph McLaughlin et al. JAMA Oncology
- Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer
- (2016) Howard I. Scher et al. JAMA Oncology
- Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial
- (2015) G. Gebhart et al. ANNALS OF ONCOLOGY
- Prospective analysis of antigen-specific immunity, stem-cell antigens, and immune checkpoints in monoclonal gammopathy
- (2015) M. V. Dhodapkar et al. BLOOD
- In Silico Prescription of Anticancer Drugs to Cohorts of 28 Tumor Types Reveals Targeting Opportunities
- (2015) Carlota Rubio-Perez et al. CANCER CELL
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts
- (2015) David Roulois et al. CELL
- From DNA Damage to Nucleic Acid Sensing: A Strategy to Enhance Radiation Therapy
- (2015) L. Deng et al. CLINICAL CANCER RESEARCH
- Comparison of MR/Ultrasound Fusion–Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer
- (2015) M. Minhaj Siddiqui et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Diagnostic Challenges of Clonal Heterogeneity in Prostate Cancer
- (2015) Michael C. Haffner et al. JOURNAL OF CLINICAL ONCOLOGY
- Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer
- (2015) Malcolm D. Mason et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization
- (2015) Michael C Haffner et al. JOURNAL OF PATHOLOGY
- The evolutionary history of lethal metastatic prostate cancer
- (2015) Gunes Gundem et al. NATURE
- Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue
- (2015) Colin S Cooper et al. NATURE GENETICS
- DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
- (2015) Joaquin Mateo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting
- (2015) Andrea K. Miyahira et al. PROSTATE
- Myeloid-Derived Cells in Tumors: Effects of Radiation
- (2015) Ralph E. Vatner et al. SEMINARS IN RADIATION ONCOLOGY
- Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer
- (2015) Matthew K.H. Hong et al. Nature Communications
- AR function in promoting metastatic prostate cancer
- (2014) Michael A. Augello et al. CANCER AND METASTASIS REVIEWS
- Diffusion-Weighted Imaging in Cancer: Physical Foundations and Applications of Restriction Spectrum Imaging
- (2014) Nathan S. White et al. CANCER RESEARCH
- Organoid Cultures Derived from Patients with Advanced Prostate Cancer
- (2014) Dong Gao et al. CELL
- STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
- (2014) Seng-Ryong Woo et al. IMMUNITY
- Intense Androgen-Deprivation Therapy With Abiraterone Acetate Plus Leuprolide Acetate in Patients With Localized High-Risk Prostate Cancer: Results of a Randomized Phase II Neoadjuvant Study
- (2014) Mary-Ellen Taplin et al. JOURNAL OF CLINICAL ONCOLOGY
- Beyond immune checkpoint blockade: New approaches to targeting host-tumor interactions in prostate cancer: Report from the 2014 Coffey-Holden prostate cancer Academy meeting
- (2014) Andrea K. Miyahira et al. PROSTATE
- Entropy, complexity, and Markov diagrams for random walk cancer models
- (2014) Paul K. Newton et al. Scientific Reports
- Rationale for and Review of Neoadjuvant Therapy Prior to Radical Prostatectomy for Patients with High-Risk Prostate Cancer
- (2013) Rana R. McKay et al. DRUGS
- Targeted Androgen Pathway Suppression in Localized Prostate Cancer: A Pilot Study
- (2013) Elahe A. Mostaghel et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiation-Induced Equilibrium Is a Balance between Tumor Cell Proliferation and T Cell-Mediated Killing
- (2013) H. Liang et al. JOURNAL OF IMMUNOLOGY
- Optimization of Initial Prostate Biopsy in Clinical Practice: Sampling, Labeling and Specimen Processing
- (2013) Marc A. Bjurlin et al. JOURNAL OF UROLOGY
- Ex vivo culture of human prostate tissue and drug development
- (2013) Margaret M. Centenera et al. Nature Reviews Urology
- Beyond the androgen receptor: New approaches to treating metastatic prostate cancer. Report of the 2013 Prouts Neck Prostate Cancer Meeting
- (2013) Kenneth J. Pienta et al. PROSTATE
- DNA Methylation Alterations Exhibit Intraindividual Stability and Interindividual Heterogeneity in Prostate Cancer Metastases
- (2013) M. J. Aryee et al. Science Translational Medicine
- A Hormone-DNA Repair Circuit Governs the Response to Genotoxic Insult
- (2013) J. F. Goodwin et al. Cancer Discovery
- Androgen Receptor Signaling Regulates DNA Repair in Prostate Cancers
- (2013) W. R. Polkinghorn et al. Cancer Discovery
- The reactive stroma microenvironment and prostate cancer progression
- (2012) David A Barron et al. ENDOCRINE-RELATED CANCER
- A Systematic Review of Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer
- (2012) Joshua J. Meeks et al. EUROPEAN UROLOGY
- Passenger deletions generate therapeutic vulnerabilities in cancer
- (2012) Florian L. Muller et al. NATURE
- Regulatory T Cells in Radiotherapeutic Responses
- (2012) Dörthe Schaue et al. Frontiers in Oncology
- A historical perspective on the role of stroma in the pathogenesis of benign prostatic hyperplasia
- (2011) Gerald R. Cunha et al. DIFFERENTIATION
- Molecular States Underlying Androgen Receptor Activation: A Framework for Therapeutics Targeting Androgen Signaling in Prostate Cancer
- (2011) Peter S. Nelson JOURNAL OF CLINICAL ONCOLOGY
- Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy
- (2011) Scott E. Eggener et al. JOURNAL OF UROLOGY
- Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial
- (2011) Padraig Warde et al. LANCET
- Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer
- (2010) E C Dijkers et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Examining the Metastatic Niche: Targeting the Microenvironment
- (2010) Theresa Guise SEMINARS IN ONCOLOGY
- DNA Hypomethylation Arises Later in Prostate Cancer Progression than CpG Island Hypermethylation and Contributes to Metastatic Tumor Heterogeneity
- (2008) Srinivasan Yegnasubramanian et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started